📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

ONYXPharmaceuticals

Onyx Gold Corp — Financial Ratios & Key Metrics

₹34.00

+0.78%

P/E Ratio62.70xIndustry: 31.77x

ROE10.43%Return on equity

ROCE12.16%Return on capital

Debt/Equity0.29Low debt

💎

Valuation & Profitability

P/E Ratio

62.70x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹67.09 (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

N/A

📉

Price Returns

1 Month

-5.13%

3 Months

-27.45%

6 Months

-24.02%

1 Year

-31.73%

52W Low

₹28

Current

₹34

52W High

₹46

32% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹37

▼ Price below SMA 50 — Bearish

SMA 200

₹N/A

▼ Long-term downtrend

Volume Signal

243% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Onyx Gold Corp

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.